• Cesca Therapeutics Inc. to Exhibit at Several Upcoming Cell Therapy Conferences

    Source: Nasdaq GlobeNewswire / 25 Apr 2018 13:30:10   Europe/London

    RANCHO CORDOVA, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ:KOOL) today announced that the Company will be exhibiting its full suite of cellular processing solutions, including CAR-TXpress™ for the semi-automated manufacture of CAR-T cell therapies, X-BACS™ for cell isolation and other X-Series™ kits, at the following cell therapy conferences in May:

    • International Society of Cellular Therapy 2018 Annual Meeting

                May 2 – 5, 2018
                Booth: 322
                Palais des congrès de Montréal
                1001, Place Jean-Paul-Riopelle
                Montreal, Canada
                For more information: www.isct2018.com 

    • American Society of Gene and Cell Therapy 2018 Annual Meeting

                May 16 – 19, 2018
                Booth: 417
                Hilton Chicago
                720 South Michigan Avenue
                Chicago, IL 60605
                For more information: www.asgct.org/meetings-workshops/annual-meeting 

    • Phacilitate Automation Special Interest Group 2018

                May 30 – 31, 2018
                The Grove
                Chandler’s Cross,
                Watford WD3 4TG, Hertfordshire
                London, UK
                For more information: www.phacilitateautomation.com 

    About Cesca Therapeutics Inc.
    Cesca Therapeutics develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. Its device division, ThermoGenesis, provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. The Company is developing an automated, functionally-closed CAR-TXpress™ platform that addresses the critical unmet need for better cellular manufacturing and controls for the emerging CAR-T immunotherapy market. Cesca is an affiliated company of China-based Boyalife Group.

    Company Contact:
    Cesca Therapeutics Inc.
    Wendy Samford
    916-858-5191
    ir@cescatherapeutics.com 

    Investor Contact:
    Rx Communications
    Paula Schwartz
    917-322-2216
    pschwartz@rxir.com 

    Primary Logo

Share on,